1. Adachi M, Maeda K, Takekawa M, Hinoda Y, Imai K, Sugiyama S, et al. High expression of CD56 (N-CAM) in a patient with cutaneous CD4-positive lymphoma. Am J Hematol. 1994; 47:278–282. PMID:
7526680.
Article
2. Bueno C, Almeida J, Lucio P, Marco J, Garcia R, de Pablos JM, et al. Incidence and characteristics of CD4(+)/HLA DRhi dendritic cell malignancies. Haematologica. 2004; 89:58–69. PMID:
14754607.
3. Oshimi K, Kawa K, Nakamura S, Suzuki R, Suzumiya J, Yamaguchi M, et al. NK-cell neoplasms in Japan. Hematology. 2005; 10:237–245. PMID:
16019472.
Article
4. Kim Y, Kang MS, Kim CW, Sung R, Ko YH. CD4+CD56+ lineage negative hematopoietic neoplasm: so called blastic NK cell lymphoma. J Korean Med Sci. 2005; 20:319–324. PMID:
15832009.
5. Lee M, Ko Y, Kim K, Kim M, Kim M, Cho K. Clinicopathologic and genetic study of cutaneous blastic NK lymphoma in Korea. Korean J Dermatol. 2007; 45(suppl 2):145.
6. Petrella T, Dalac S, Maynadié M, Mugneret F, Thomine E, Courville P, et al. Groupe Français d'Etude des Lymphomes Cutanés (GFELC). CD4+CD56+ cutaneous neoplasms: a distinct hematological entity? Am J Surg Pathol. 1999; 23:137–146. PMID:
9989839.
7. Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005; 105:3768–3785. PMID:
15692063.
Article
8. Chaperot L, Bendriss N, Manches O, Gressin R, Maynadie M, Trimoreau F, et al. Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood. 2001; 97:3210–3217. PMID:
11342451.
Article
9. Jaye DL, Geigerman CM, Herling M, Eastburn K, Waller EK, Jones D. Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms. Mod Pathol. 2006; 19:1555–1562. PMID:
16998465.
Article
10. Cota C, Vale E, Viana I, Requena L, Ferrara G, Anemona L, et al. Cutaneous manifestations of blastic plasmacytoid dendritic cell neoplasm-morphologic and phenotypic variability in a series of 33 patients. Am J Surg Pathol. 2010; 34:75–87. PMID:
19956058.
Article
11. Rönnblom L, Pascual V. The innate immune system in SLE: type I interferons and dendritic cells. Lupus. 2008; 17:394–399. PMID:
18490415.
Article
12. Jegalian AG, Facchetti F, Jaffe ES. Plasmacytoid dendritic cells: physiologic roles and pathologic states. Adv Anat Pathol. 2009; 16:392–404. PMID:
19851130.
13. Vermi W, Lonardi S, Morassi M, Rossini C, Tardanico R, Venturini M, et al. Cutaneous distribution of plasmacytoid dendritic cells in lupus erythematosus. Selective tropism at the site of epithelial apoptotic damage. Immunobiology. 2009; 214:877–886. PMID:
19625100.
Article
14. Leitenberger JJ, Berthelot CN, Polder KD, Pro B, McLaughlin P, Jones D, et al. CD4+ CD56+ hematodermic/plasmacytoid dendritic cell tumor with response to pralatrexate. J Am Acad Dermatol. 2008; 58:480–484. PMID:
18280345.
Article
15. Dalle S, Beylot-Barry M, Bagot M, Lipsker D, Machet L, Joly P, et al. Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice? Br J Dermatol. 2010; 162:74–79. PMID:
19689477.
Article